BioCentury
ARTICLE | Company News

Biovail, J&J, sanofi-aventis sales and marketing update

January 5, 2009 8:00 AM UTC

Biovail recalled certain lots of Ultram ER 100 mg tablets after batches were found to be out-of-specification by about 1% with respect to maximum dissolution at the eight-hour mark. The company said the dissolution variance relates to excipients used in the coating process and does not affect patient health or safety. Johnson & Johnson markets the once-daily formulation of tramadol to treat moderate and moderately severe pain in adults who require continuous therapy for several days or more. ...